Explore more than 1.3 million company profiles from emerging markets

Pt Indofarma Tbk (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 256.00
Volume 800,500
Turnover 206,529,000
Index Jakarta Composite Index
Market Indonesia Stock Exchange
Ticker INAF
Market Cap Market Cap 793,412,608
52 Week High 372.00
52 Week Low 153.00
P/E 680.41
EPS 0.38
Dividend Yield 19.77 (December 04, 2002)
Bookvalue 1,232,642,951
Enterprise Value 673,359,550
Quote updated on May 26, 2015
Note: data in IDR Thousands.
Financials
Select Items to chart them. 2014 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets 1,248,343,275
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

PT. Indofarma (Persero) Tbk. (INAF), operates as a state-owned enterprise that produce pharmaceuticals and health products. INAF's products are marketed both domestically and internationally. INAF manufactures and distributes pharmaceuticals products, including ethical and OTC products. INAF also markets and distributes health products. INAF's ethical products include generic medicines and trademarked medicines, while its OTC products are classified into: OTC medicines, herbal medicines and health food.…

More
Main Products

Pharmaceuticals and health products.

Contact Information

Legal Address
Jl. Indofarma No.1
Cikarang; West Java; Map
Postal Code: 17530
Tel: +62-21-8832-3971,+62-21-8832-3975
Fax: +62-21-8832-3972
Email: general@indofarma.co.id
Website: http://www.indofarma.co.id

Full name: Pt Indofarma Tbk

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN CODE : ID1000068406
Incorporation Date: 1996

Basic Information
Total Employees:
()
Outstanding Shares:
: ()
Financial Auditors:
()
Key Executives
President
Ownership Details
The Government Of The Republic Of Indonesia
80.66%
Other
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Indonesia
IDR | USD | EUR
Analysis/Research

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.